Infants have a higher risk of developing allergic asthma than adults. However, the underlying mechanism remains unknown. We show here that sensitization of mice with house-dust mites (HDMs) in the presence of low-dose lipopolysaccharide (LPS) prevented T helper 2 (Th2) cell allergic responses in adult, but not infant, mice. Mechanistically, adult CD11b + migratory dendritic cells (mDCs) upregulated the transcription factor T-bet in response to tumor necrosis factor-a (TNF-a), which was rapidly induced after HDM + LPS sensitization. Consequently, adult CD11b + mDCs produced interleukin-12 (IL-12), which prevented Th2 cell development by promoting T-bet upregulation in responding T cells. Conversely, infants failed to induce TNF-a after HDM + LPS sensitization. Therefore, CD11b + mDCs failed to upregulate T-bet and did not secrete IL-12 and Th2 cell responses normally developed in infant mice. Thus, the availability of TNF-a dictates the ability of CD11b + mDCs to suppress allergic Th2-cell responses upon dose-dependent endotoxin sensitization and is a key mediator governing susceptibility to allergic airway inflammation in infant mice.
INTRODUCTION
Asthma is the most common chronic disease of childhood and currently affects $10% of school-aged children in the US (Masoli et al., 2004) . About 95% of those children begin developing asthma in very early childhood, normally before they turn 5 years of age (Masoli et al., 2004) . Most cases of pediatric asthma are triggered by early sensitization to common environmental allergens, which ultimately leads to the activation of T helper 2 (Th2) cells and the development of chronic Th2-cell-driven lung inflammation (Reynolds and Finlay, 2017) . Despite the epidemiological and mechanistic studies, however, the underlying mechanisms for the high susceptibility to airway allergic inflammation and asthma development in infants remain elusive.
The incidence of allergic airway disease has increased over the past decades in industrialized countries (Masoli et al., 2004) . Although numerous environmental factors associated with this change of lifestyle might have contributed to this rise, the hygiene hypothesis proposes that the decreased exposure to microbial products is one of the main drivers of allergic airway disease. Supporting this idea, exposure to microbial products, such as lipopolysaccharide (LPS), protects from the development of experimental-allergen-induced asthma (Daan de Boer et al., 2013; Schuijs et al., 2015) . In addition, infants sensitized to common circulating allergens in a ''clean'' environment are at a higher risk of developing asthma later in life than infants exposed to high levels of enviromental endotoxin (Gereda et al., 2000; Reynolds and Finlay, 2017; Schuijs et al., 2015; Stein et al., 2016; Zhu et al., 2010) , thus suggesting a particular requirement for high endotoxin exposure during infancy for allergic asthma protection, although this requirement is not fully understood.
Dendritic cells (DCs) are the main antigen-presenting cells for T cell activation and polarization. In lymph nodes (LNs), DCs can be broadly divided into LN-resident DCs (rDCs) and migratory DCs (mDCs), which differentiate in peripheral tissues and migrate constantly through afferent lymphatics to the draining LN. Both rDCs and mDCs contain two major subsets: IRF8-dependent CD103 + DCs (recently named cDC1s) and IRF4-dependent CD11b + DCs (recently named cDC2s) (Guilliams et al., 2014) . Although the roles of the various DC subsets are not fully understood, CD11b + mDCs have been shown to be critical for the development of Th2 cell responses to common allergens (Leó n, 2017; Plantinga et al., 2013) . In contrast, CD103 + mDCs are likely to prevent the development of allergic inflammation (Conejero et al., 2017) . Whether alterations in individual DC subsets during infancy contribute to asthma susceptibility remains unexplored.
Here, we show that CD11b + mDCs from adult mice upregulated the transcription factor T-bet and produced interleukin-12 (IL-12) after house-dust-mite (HDM) sensitization in the presence of LPS. mDCs in adult mice upregulated T-bet, which precluded Th2 cell differentiation and subsequent pathogenic allergic responses to HDMs. We found that the upregulation of T-bet on CD11b + mDCs was dependent on TNF-a production and TNFR signaling. Adults rapidly produced TNF-a in response to low-dose LPS sensitization; however, infant mice had an impaired ability to produce TNF-a in response to LPS. As a result, CD11b + mDCs from infant mice failed to upregulate T-bet and IL-12 in low-LPS conditions. Thus, CD4 + T cells interacting with CD11b + mDCs in infants failed to receive IL-12 signals, did not upregulate T-bet, and fully differentiated into pathogenic Th2 cells. Thus, whereas low-LPS exposure during HDM sensitization protected adult mice from developing Th2-driven allergic asthma, infant mice required higher doses of LPS. Collectively, our data demonstrate that LPS prevents Th2-dependent allergic responses with different thresholds in adults and infants and provide a plausible mechanism underlying the higher susceptibility to allergic airway inflammation observed in children.
RESULTS

LPS Inhibits Th2-Cell-Mediated Immunity to Inhaled HDMs with Different Thresholds in Infant and Adult Mice
To test whether LPS influenced Th2 cell response to HDM sensitization in infancy and adulthood, we intranasally (i.n.) sensitized adult (R8-week-old) and infant (18-day-old) IL-4 reporter B6.4get mice with HDMs in the presence or absence of different amounts of LPS (sensitization phase; Figure 1A ). We then challenged them i.n. with HDMs (challenge phase; Figure 1A ) and determined the frequency ( Figure 1B ) and number ( Figure 1C Figure 1H ) and improved peripheral-blood arterial oxygen saturation (SpO2) ( Figure 1I ). Similar differences from adults were observed in neonatal (7-day-old), early infant (14-day-old), and infant (18-day-old) mice ( Figures S2A-S2J ).
Altogether, these data indicate that exposure to relatively low endotoxin amounts, in a defined time window from the neonatal to infant period, fails to prevent the development of Th2 cell responses and allergic inflammation to inhaled HDMs.
The Environment of Infants Is More Resistant to LPS and More Prone to Prime HDM-Specific Th2 Cell Responses Than That of Adults
The development of allergen-specific Th2 effector cells that migrate to the lungs requires T cell priming in the mLN, which occurs after initial sensitization (Ballesteros-Tato et al., 2016) . Therefore, we next enumerated GFP + CD44 hi CD4 + T cells in the mLN of adult and 18-day-old infant B6.4get mice during the sensitization phase ( Figure 1J ). The frequency (Figures 1K and 1L) and number ( Figure 1M ) of GFP + CD4 + T cells were significantly lower in HDM + LPS lo -sensitized adult mice than in HDMsensitized adult mice. In contrast, LPS lo did not prevent the accumulation of GFP + CD4 + T cells in infants ( Figures 1K-1M ).
Similar results were found in 7-and 14-day-old mice (Figure S2K) . Lung neutrophilia were not examined because they are unlikely to significantly affect Th2 cell priming. These results suggest that low-dose LPS prevents Th2 cell priming in the mLN after HDM sensitization in adult, but not in neonatal or infant, mice. Next, we tested whether the differential capacity of lowdose LPS to prevent Th2 cell priming in adults and infants is dictated by intrinsic differences in the CD4 + T cell compartment ( Figures 1N-1Q ). We transferred 4get.OT-II TCR-transgenic CD4 + T cells from adult or infant mice into congenic adult recipients ( Figure 1N ). Recipients were then i.n. sensitized with HDM + endotoxin-free ovalbumin (HDM + OVA) ± LPS lo , and donor 4get.OT-II (CD45.1 + ) cells were analyzed for the expression of GFP-IL-4 in the mLN ( Figures 1O-1Q ). Data showed that the differential capacity of LPS lo to prevent Th2 cell development in adults and infants was not due to intrinsic differences in the CD4 + T cells. We next transferred 4get.OT-II cells from adult mice into adult or infant recipients ( Figure 1R ). Those were then sensitized with HDM + OVA ± LPS lo , and donor-derived GFP + cells were analyzed ( Figures 1S-1U ). LPS lo failed to prevent the accumulation of donor-derived GFP + 4get.OT-II cells when developing in infant, but not in adult, recipients ( Figures  1S-1U ). i.n. HDM + LPS delivery was similarly effective in adults and infants ( Figures S2L-S2N ). Similar results were obtained when sensitization was given intratracheally (i.t.) rather than i.n. (Figures S2O-S2Q ). Thus, whereas low-LPS prevents Th2 cell differentiation in adult mice after HDM sensitization, the environment of the infants is more resilient to LPS; hence, infants are at higher risk for priming allergen-specific Th2 cell responses in the presence of low doses of endotoxin.
Infants Do Not Induce T-bet Expression in T Cells under LPS
lo Sensitization T-bet suppresses the Th2-cell-associated program (Zhu et al., 2012) . To test whether CD4 + T cells developing in an infant or adult environment differently upregulate T-bet, we transferred 4get.OT-II cells from adult mice into either adult or infant recipients, sensitized them, and analyzed the dynamics of T-bet expression ( Figures 2A-2C and S3A). As expected, LPS lo treatment prevented the accumulation of 4get.OT-II GFP + cells in adult mice, but not infant mice, from day 5 ( Figure 2B ). Importantly, 4get.OT-II cells expressed higher amounts of T-bet when developing in adults sensitized with HDM + OVA + LPS lo than when developing in non-LPS-sensitized recipients (Figure 2C) . Further, this upregulation of T-bet occurred concomitantly with the downregulation of GATA-3 ( Figures S3B-S3D ). In contrast, 4get.OT-II cells failed to upregulate T-bet in HDM + OVA + LPS lo -sensitized infants ( Figure 2C Figures S3H-S3K) . Moreover, the frequency ( Figure S3H ) and number ( Figures S3I-S3K ) of HDM-bearing, Alexa-647 + CD11b mDCs and CD103 + mDCs were identical in infants and adults. Thus, the differences in Th2 cell responses between adults and infants after HDM + LPS lo sensitization were not due to differences in the number, or the capacity, of mDC subsets to capture and transport HDM-derived Ags into the mLN but to their functional capacity to induce T-bet expression in T cells.
T-bet Expression by CD11b + mDCs Is Required for Preventing Th2 Cell Responses to HDMs
Few reports have suggested that intrinsic T-bet expression might fine-tune the capacity of DCs to differentially induce Th1 and Th2 cells (Lipscomb et al., 2009; Lugo-Villarino et al., 2003) . Thus, we next used T-bet-ZsGreen reporter mice (Zhu et al., 2012) Please also see Figure S3 . (E-J) B6 adult and 18-day-old infant mice were i.n. treated with HDM + 5 mg LPS. Shown are frequencies of T-bet expression at 72 hr (E and F) and kinetics of IRF4 (G), IRF1 (H), IFR5 (I), and T-bet (J) expression in mLN CD11b + and CD103 + mDCs.
***p < 0.001 (unpaired Student's t test). Data are representative of at least two independent experiments (mean and SD of three or four mice per group).
2.3% ±1.3 1.3% ±1.5
1.4% ±0.5 8.9% ±0.9
1.7% ±0.4 11.1% ±0.9
1.3% ±1.5 13.4% ±2.6 Thus, we also investigated whether HDM + LPS lo sensitization differentially affects the expression of IRF members in infant and adult mDCs. Although CD11b + mDCs from HDM + LPS losensitized adult and infant mice differentially upregulated T-bet expression ( Figure 3J ), no differences were observed in the expression of IRF4 ( Figure 3G ), IRF1 ( Figure 3H ), or IRF5 (Figure 3I) Figure S4C ). All CD11c hi DCs, including CD103 + mDCs, CD11b + mDCs, and rDCs, expressed GFP (Figure S4D ) and were expected to have equimolar expression with Cre (Stranges et al., 2007) . Plasmacytoid DCs expressed lower amounts of GFP than other DC subpopulations ( Figure S4D ) (Stranges et al., 2007) . As predicted, mLN CD11b + mDCs of HDM + LPS lo -sensitized Itgax cre -Tbx21 fl/fl mice failed to express T-bet ( Figures S4E and S4F ). Thus, we next transferred OT-II cells into either Itgax cre -Tbx21 fl/fl or control mice. Recipients were then sensitized and challenged, and donor OT-II cells were analyzed in the lungs ( Figure 4E ). As expected, the frequency ( Figures 4F and 4G ) and number ( Figure 4H) Figure 4N ). The frequency ( Figure 4O ) and number ( Figure 4P ) of GFP + CD69
+-
CD44
hi CD4 + responding T cells were determined in the mLN.
As a control, some mice were also sensitized with infant DCs. Purified lung CD11c + cells were enriched over 80% in mDCs ( Figure S4L ) and were recovered in similar numbers in the mLN of all groups ( Figures S4M and S4N ). Importantly, from the different donor mDC types, only the donor mDCs from HDM + LPS--sensitized adult mice were able to prevent the accumulation of activated GFP + CD4 + T cells in the infant recipients (Figures 4O and 4P) . Collectively, these data suggest that upregulation of T-bet in lung mDCs is required for preventing Th2 cell responses to low-dose endotoxin and HDM sensitization. In fa n t (C) mLN CD11b + mDCs from B6 adults and 18-day-old infants were sorted 24 hr after being i.n. treated with HDM + 5 mg LPS, and RNA-seq was performed.
Shown are the NES and number of downregulated genes in infant CD11b + mDCs for each of the top ten hallmark signaling pathways resulting from GSEA (Broad institute; adjusted p value < 0.05, log 2 fold change > 0.58).
(D and E) B6 adults and 18-day-old infants were i.n. treated with HDM ± 5 mg LPS or HDM ± 30 mg TNF. Some mice also received 250 mg anti-TNF-a intraperitoneally (i.p. (Table S1 ). Notably, the pathway regulated by nuclear factor kappa B (NF-kB) in response to TNF-a had the highest normalized enrichment score (NES = 2.64, FDR q-value = 1.28e À42 ) and contained the largest number of genes downregulated in infant CD11b + mDCs ( Figures 6C, S6A , and S6B; Tables S2 and S3 ). TNF-a activates the NF-kB and activator protein-1 (AP-1) transcription factors (Verstrepen et al., 2008) . Expression of genes encoding NF-kB-c-rel and the AP-1 family members c-Jun, JunB, c-Fos, and FosB was decreased in infant CD11b + mDCs after HDM + LPS lo sensitization (Table S1 ). We next evaluated c-Rel and P-cJun expression in adult and infant mLN CD11b + mDCs. Adult CD11b + mDCs, but not infant CD11b + mDCs, induced c-Rel and P-c-Jun in response to HDM + LPS lo sensitization ( Figures   S6C-S6E ). We next tested whether LPS-induced TNF-a plays a role in the activation of NF-kB and AP-1 in CD11b + mDCs. Therefore, we evaluated the expression of NF-kB-c-Rel, the NF-kB early response protein IkBz, and P-c-Jun-AP-1 in adult mLN CD11b + mDCs after sensitization in the presence or absence of TNF-a-neutralizing monoclonal antibody (mAb) or TNF-a cytokine. As a control, we also included the analysis of 18-day-old infant CD11b + mDCs. As expected, adult CD11b + mDCs, but not infant CD11b + mDCs, induced c-Rel, IkBz, and P-c-Jun in response to HDM + LPS lo sensitization ( Figures 6D   and 6E ). However, anti-TNF-a treatment prevented these effects ( Figures 6D and 6E) . Additionally, compared with HDM sensitization alone, HDM sensitization in the presence of TNF-a cytokine was able to induce c-Rel, IkBz, and P-c-Jun expression in CD11b + mDCs ( Figures 6D and 6E Figures 6G and 6I ). Together, these data suggest that in adults, HDM + LPS lo sensitization induces activation of NF-kB and AP-1 and T-bet upregulation in CD11b + mDCs by LPS-induced TNF-a production and TNFa-mediated signaling.
To test whether TNF-a-mediated signaling in DCs is required for suppressing Th2 cell priming in response to low-dose endotoxin sensitization, we generated BM chimeras that expressed TNFR normally (DC-WT) or that were selectively TNFR deficient in CD11c + DCs after diphtheria toxin ( *p < 0.05, **p < 0.01, ***p < 0.001 (unpaired Student's t test). Data are representative of two independent experiments (mean and SD of three to seven mice per group). Please also see Figure S6 and Tables S1-S3 . but only a moderate increase in infants ( Figure 7A ). These differences were also observed between adults and 7-to 14-day-old mice (data not shown). No differences between adults and infants were found in the expression of other cytokines such as IL-1a, IL-1b ( Figure 7A) , and IL-6 (data not shown). These data indicate that infants have defective production of TNF-a after HDM + LPS lo sensitization. To test whether defective T-bet upregulation in infant CD11b + mDCs after HDM + LPS lo sensitization is due to defective TNF-a production, we sensitized 18-day-old T-bet-ZsGreen mice with HDM + LPS lo in the presence of different concentrations of TNF-a and determined the expression of T-bet in mLN CD11b + mDCs. As expected, HDM + LPS lo sensitization did not induce significant upregulation of T-bet in CD11b + mDCs from infant mice ( Figures 7B and 7C) . However, co-administration of TNF-a induced T-bet upregulation in infant CD11b + mDCs to amounts similar to those found in CD11b + mDCs from HDM + LPS lo -sensitized adults ( Figures 7B and   7C ). Similar upregulation of T-bet in CD11b + mDCs was seen from 7-, 14-, and 18-day-old mice after exogenous administration of TNF-a ( Figures S7A and S7B) . Thus, our data indicate that defective TNF-a production in infants prevents T-bet upregulation in CD11b + mDCs after HDM + LPS lo sensitization. In addition, administration of TNF-a during HDM + LPS lo sensitization recovers the capacity of infant mLN CD11b + mDCs to produce IL-12 in amounts similar to those of adult CD11b + mDCs ( Figures 7D and 7E ). Finally, we tested whether administration of TNF-a during HDM + LPS lo sensitization restores the capacity of low-LPS treatment to abrogate Th2 cell development in infant mice. We transferred 4get.OT-II CD4 + T cells into B6 adults and 18-dayold infants, sensitized them in the presence of TNF-a, and assessed expression of GFP by donor 4get.OT-II cells ( Figures  7F and 7G ). TNF-a administration restored the capacity of LPS lo to prevent GFP expression in infant mice ( Figures 7F and 7G Figures  7H and 7I) . Likewise, HDM + LPS lo sensitization in the presence of TNF-a also prevented the accumulation of lung eosinophils ( Figures 7J, S7C , and S7D) and mLN IgE + ASCs ( Figures 7K  and S7E ), prevented the induction of goblet cell hyperplasia (Figure S7F) , and improved SpO2 ( Figure 7L ) in infant mice. The same results were seen when 10-day-old mice were analyzed (data not shown). In contrast, TNF-a neutralization after HDM + LPS lo sensitization in adult mice abolished the suppressive effect of LPS on asthma, including the accumulation of IL-13 + CD4 + T cells ( Figures S7I and S7J ) and eosinophils (Figures S7G and S7H) in the lungs, the goblet cell hyperplasia ( Figure S7F) , and the beneficial effect on SpO2 ( Figure 7L ). Thus, our data indicate that defective TNF-a production prevents the suppression of Th2 cell responses to HDMs in the presence of low doses of endotoxin.
To assess the cellular source of TNF-a after HDM + LPS lo sensitization, we first evaluated whether LPS-driven TNF-a production is mediated by radioresistant (including lung epithelium) or hematopoietic cells in the lungs. Therefore, B6 (WT) or Tlr4 and 7P). Next, we evaluated whether hematopoietic cells directly respond to LPS to produce TNF-a. Thus, WT:Tlr4 À/À BM chimeras were sensitized, and TNF-a production in the lungs was determined. As expected, HDM + LPS lo sensitization induced TNF-a production ( Figure 7Q ), but importantly, TNF-a + cells
were principally restricted to the WT phenotype (Figures 7Q and 7R) , suggesting that TNF-a was produced by lung hematopoietic cells after direct recognition of LPS by TLR4. Conversely, the analysis of WT:Il1r1 À/À BM chimeras showed that lung cells did not require expression of IL-1R to produce TNF-a in response to LPS ( Figures 7Q and 7R ). These data suggest that TNF-a-dependent upregulation of T-bet in CD11b + mDCs is driven by hematopoietic cells that produce TNF-a in response to LPS, but not by epithelial cells.
Collectively, our data indicate that adult CD11b + mDCs upregulate T-bet in response to TNF-a produced after HDM + LPS lo sensitization, which in turn promotes IL-12 production, thereby preventing Th2 cell differentiation by inducing T-bet expression in responding CD4 + T cells. In contrast, in early life and during a time window from day 7 to day 20 after birth, the CD11b + mDCs fail to upregulate T-bet in response to low doses of LPS as a result of impaired production of TNF-a, which prevents optimal IL-12 production and subsequent Th2 cell inhibition despite the presence of LPS.
DISCUSSION
Previous studies in mice have shown that during a time window from day 7 to day 20 after birth, the immune system is prone to allergic sensitization and Th2-driven allergic responses (de Kleer et al., 2016; Gollwitzer et al., 2014; Steer et al., 2017) , suggesting that a ''window of opportunity'' in the postnatal period influences the immune responses to allergens. Comparative immunological evaluations have demonstrated that the immunity in mice at 7 days is comparable to that of term human neonates, whereas mice < 20 days old resemble infants (Siegrist, 2001 ). Thus, 1-to 3-week-old mice have yielded observations very similar to those of human neonates (0-2 months old) and infants (under 1-2 years old) (Siegrist, 2001 ). In correlation with animal studies, primary allergen sensitizations to environmental Ags gradually develop and peak in children 2-3 years of age (Holt, 1996) and are associated with later development of asthma and allergic disease (Lodge et al., 2011) . Therefore, both in humans and in mice, a susceptibility window for inhalant-allergen sensitization covers the neonatal and infancy periods. Several studies in mice have evaluated this propensity to develop allergic sensitization during infancy (de Kleer et al., 2016; Steer et al., 2017) . However, the understanding of the allergic sensitization process in the context of exposure to environmental endotoxins during infancy is still not clear. Previous studies have shown that LPS exposure prevents the development of allergic Th2 cell responses (Daan de Boer et al., 2013; Gereda et al., 2000; Schuijs et al., 2015; Stein et al., 2016; Zhu et al., 2010) . Our data demonstrate, however, that adults and infants respond to LPS with different thresholds. As a result, whereas relatively low-dose LPS exposure normally prevents adults from developing allergic Th2 cell responses, infant mice require a relatively high-LPS environment to achieve the same prophylactic effect. The inability of low-LPS exposure to prevent Th2 cell differentiation in infants is attributed to the inability of responding infant CD4 + T cells to upregulate T-bet, which we found was required for preventing Th2 cell development in response to HDMs. Impaired T-bet expression, however, was not due to an intrinsic defect in the infant CD4 + T cells. Gao et al., 2013; Kumamoto et al., 2013; Leó n, 2017; Plantinga et al., 2013) . As such, CD103 + mDCs produce IL-12p40 after HDM sensitization, thereby preventing Th2 cell differentiation (Conejero et al., 2017) . Here, we found that LPS prevented Th2 cell differentiation in HDM-sensitized mice by an IL-12-dependent mechanism. We found, however, that CD103 + mDCs were quickly depleted from the lung after HDM + LPS sensitization, possibly as a result of increased LPS-driven epithelial damage (Sung et al., 2006 have the ability to either promote or prevent Th2 cell responses depending on the amount of LPS. Therefore, the contribution of CD11b + mDCs relative to CD103 + mDCs to the development of allergic Th2 cell responses is more complex than initially expected and is highly influenced by the environmental number of microbial products rather than being predetermined by their intrinsic nature alone. Importantly, our data show that whereas IL-12 production by CD11b + mDCs requires the upregulation of T-bet, IL-12 production by CD103 + mDCs is T-bet independent. However, the molecular mechanisms by which T-bet is required in only CD11b + mDCs is unclear. Various transcription factors, including IRF family members, have been implicated in the regulation of IL-12 production by DC subsets (Gao et al., 2013; Takaoka et al., 2005; Taki et al., 1997; Williams et al., 2013) . Here, we found no differences in the expression of IRF1 or IRF5 between CD103 + and CD11b + mDCs from infants and adults. Importantly, the transcription factor IRF4 is highly expressed in CD11b + , but not in CD103 + , mDCs and essentially contributes to the differentiation and function of CD11b + mDCs. For example, IRF4 drives CD11b + mDCs to promote Th2 cell differentiation (Gao et al., 2013; Kumamoto et al., 2013; Williams et al., 2013) , inhibits the capacity of DCs and macrophages to produce IL-12 (Akbari et al., 2014; Honma et al., 2005) , and competes with IRF5 to inhibit IRF5-dependent upregulation of pro-inflammatory cytokines, such as IL-12 and IL-6 . These data suggest a role for IRF4 in the negative-feedback regulation of IL-12 production, and because IRF4 is restricted to CD11b + mDCs, IRF4 might selectively control IL-12 regulation specifically in CD11b + mDCs.
Therefore, one could speculate that T-bet upregulation, specifically in CD11b + mDCs, is important for overcoming the suppressive function of IRF4 in IL-12 production. In summary, our comparative analysis between adult and neonatal-infant mice offers mechanistic insights into how the priming of allergen-specific Th2 cell responses is differentially regulated during childhood and adulthood, suggests a perspective for the biological mechanism underlying the hygiene hypothesis, and provides a plausible mechanism to explain higher susceptibility to allergic airway inflammation observed in children than in adults.
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Beatriz Leó n (bleon@uab.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS Mice
The mouse strains used in these experiments include: C57BL/6J (B6), B6.SJL-Ptprc 
Lung histology
The lungs were fixed in buffered formalin (10%). Microtome sections of paraffin-embedded lungs were stained with periodic acidSchiff (PAS) for visualization of goblet cells.
Pulmonary function assessment
To measure airway responsiveness, mice on day 5 post-challenge were mechanically ventilated and challenged with increasing concentrations of methacholine, as described previously (Song et al., 2011) . Briefly, mice were anesthetized, intubated, connected to a ventilator (FlexiVent; SCIREQ, Montreal, PQ, Canada), and ventilated at a rate of 160 breaths per minute. Airway responsiveness was recorded at baseline and after a linear dose response with methacholine challenge (10-75 mg/mL; Sigma-Aldrich). Data were normalized to basal airway resistance and expressed as changes induced by methacholine. To measure arterial O 2 saturation (SpO2), the MouseOx Pulse-oximeter (Starr Life Sciences, Oakmont PA) was used on conscious mice 5 days-post-challenged, in accordance with manufacturer's instructions. Mice were shaved and the pulse-oximeter collar was placed behind the ears. To ensure accurate measurement, SpO2 data points were excluded from analysis if received an error code during measurement.
RNA-sequencing (RNA-seq ) from adult (7wks-old) and infant (2-3wks-old) mice were sorted from the mLN 24h after HDM+LPS sensitization using a FACSAria (BD Biosciences) after positive selection with anti-CD11c MACS beads (Miltenyi Biotec). RNA was isolated from the sorted cells using the RNeasy Plus Micro RNA purification kit (QIAGEN). Three or four replicates from three or four independent experiments for each condition were analyzed with RNA-seq. Library preparation and RNA sequencing was conducted through Genewiz. Libraries were sequenced using a 1Å $50-bp single end rapid run on the HiSeq2500 platform. Sequence reads were trimmed to remove possible adaptor sequences and nucleotides with poor quality (error rate < 0.05) at the end. After trimming, sequence reads shorter than 30 nucleotides were discarded. Remaining sequence reads were mapped to the Mus musculus mm10 reference genome using CLC genomics workbench v. 9.0.1. Differential gene expression was determined using DESeq2. Genes with an adjusted P value < 0.05 and an absolute log1.5-fold change (ratio ± 0.58) were considered significantly differentially expressed genes between adult and infant mCD11b + DCs.
GSEA, hierarchical clustering and visualization of RNA sequencing results. GSEA was performed using the Molecular Signatures Database on the publically available MIT BROAD Institute server. We ranked the 173 genes obtained from RNA sequencing (Genewiz) according to a logarithmic transformation of each gene's P value multiplied by the sign of the corresponding logarithmic fold change, and subsequently used these rank lists to perform a gene set enrichment analysis (Broad Institute's GSEA Java app, version 3.0). Given gene sets can include both activated and repressed genes, we additionally performed an extended enrichment assessment of all identified gene sets. Separately, we performed hierarchical clustering analysis (Bar-Joseph et al., 2001; Eisen et al., 1998) of TNFa induced genes that are differentially expressed in adult versus infant mice, using MATLAB (version R2017b). Differential clusters are presented in form of an annotated heatmap based on standardized expression values, along with the resulting hierarchical clustering dendogram.
QUANTIFICATION AND STATISTICAL ANALYSIS
All plots and histograms were plotted in FlowJo v.9 software (Treestar). GraphPad Prism software (Version 7) was used for data and statistical analysis. Data were analyzed using the unpaired Student's t test. Values of p < 0.05 were considered significant (*p < 0.05, **p < 0.01, ***p < 0.001).
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The accession number for the raw data files for the RNA-Seq analyses reported in this paper is GEO: GSE110046.
